Content Analysis: Apr.30 -- Dave Ricks, chairman and chief
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Eli Lilly
Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Eli Lilly
Eli Lilly CEO: Our pill supply can 'reach the planet'
Eli Lilly
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Eli Lilly
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
NBC News' Tom Llamas talks to
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
(0:00) Introducing
Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic
Eli Lilly CEO
Eli Lilly CEO David Ricks tells a global audience what the company is planning for Huntsville
Eli Lilly's CEO
Eli Lilly CEO on 1Q Results, Drug Pricing, Pharma Margins
Apr.30 -- Dave Ricks, chairman and chief
Reinventing Strategy for a Global Era: Eli Lilly and Company
Sidney Taurel, Chairman of
Watch CNBC's full interview with Eli Lilly CEO David Ricks
David Ricks,
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Dave Ricks, the
AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years
Eli Lilly
